AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Net Block History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Block | ₹14,794 Cr | ₹14,493 Cr | ₹11,024 Cr | ₹10,532 Cr | ₹9,374 Cr |
What is the latest Net Block ratio of AUROBINDO PHARMA ?
| Year | Net Block |
|---|---|
| Mar2025 | ₹14,794 Cr |
| Mar2024 | ₹14,493 Cr |
| Mar2023 | ₹11,024 Cr |
| Mar2022 | ₹10,532 Cr |
| Mar2021 | ₹9,374 Cr |
How is Net Block of AUROBINDO PHARMA Trending?
| Years | Net Block | % Change | |
|---|---|---|---|
| Mar2025 | ₹14,794 Cr | 2.08 | |
| Mar2024 | ₹14,493 Cr | 31.47 | |
| Mar2023 | ₹11,024 Cr | 4.67 | |
| Mar2022 | ₹10,532 Cr | 12.36 | |
| Mar2021 | ₹9,374 Cr | - | |
Compare Net Block of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹75,283.3 Cr | 4% | 13.1% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 4% |
13.1% |
19.7% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses